Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Where this comes from
- Record sourced from PubMed, PMID 31729370.
- Also identified by DOI 10.1038/s41467-019-13151-z and PMC identifier 6858433.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.